Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,637 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating Outcome Prediction via Baseline, End-of-Treatment, and Delta Radiomics on PET-CT Images of Primary Mediastinal Large B-Cell Lymphoma.
Yousefirizi F, Gowdy C, Klyuzhin IS, Sabouri M, Tonseth P, Hayden AR, Wilson D, Sehn LH, Scott DW, Steidl C, Savage KJ, Uribe CF, Rahmim A. Yousefirizi F, et al. Among authors: wilson d. Cancers (Basel). 2024 Mar 8;16(6):1090. doi: 10.3390/cancers16061090. Cancers (Basel). 2024. PMID: 38539425 Free PMC article.
Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma.
El-Galaly TC, Villa D, Alzahrani M, Hansen JW, Sehn LH, Wilson D, de Nully Brown P, Loft A, Iyer V, Johnsen HE, Savage KJ, Connors JM, Hutchings M. El-Galaly TC, et al. Among authors: wilson d. Am J Hematol. 2015 Nov;90(11):1041-6. doi: 10.1002/ajh.24169. Am J Hematol. 2015. PMID: 26260224 Free article.
Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP.
Freeman CL, Savage KJ, Villa DR, Scott DW, Srour L, Gerrie AS, Brown MJ, Slack GW, Farinha P, Skinnider B, Morris J, Bénard F, Aquino-Parsons C, Lo A, Pickles T, Wilson DC, Tonseth P, Connors JM, Sehn LH. Freeman CL, et al. Blood. 2021 Feb 18;137(7):929-938. doi: 10.1182/blood.2020005846. Blood. 2021. PMID: 32871586 Free article.
Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD.
Villa D, Sehn LH, Aquino-Parsons C, Tonseth P, Scott DW, Gerrie AS, Wilson D, Bénard F, Gascoyne RD, Slack GW, Farinha P, Morris J, Pickles T, Connors JM, Savage KJ. Villa D, et al. Among authors: wilson d. Haematologica. 2018 Dec;103(12):e590-e593. doi: 10.3324/haematol.2018.196782. Epub 2018 Jul 12. Haematologica. 2018. PMID: 30002124 Free PMC article. No abstract available.
Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach.
Cheng PTM, Villa D, Tonseth RP, Scott DW, Gerrie AS, Freeman CL, Pickles T, Lo AC, Farinha P, Craig JW, Slack GW, Gascoyne RD, Bénard F, Wilson D, Skinnider B, Connors JM, Sehn LH, Savage KJ. Cheng PTM, et al. Among authors: wilson d. Blood Adv. 2021 Sep 28;5(18):3647-3655. doi: 10.1182/bloodadvances.2021004375. Blood Adv. 2021. PMID: 34438445 Free PMC article.
The outcome of older adults with classic Hodgkin lymphoma in British Columbia.
Cheng PTM, Villa D, Gerrie AS, Freeman CL, Slack GW, Gascoyne RD, Farinha P, Craig JW, Skinnider B, Wilson D, Scott DW, Connors JM, Sehn LH, Savage KJ. Cheng PTM, et al. Among authors: wilson d. Blood Adv. 2022 Nov 22;6(22):5924-5932. doi: 10.1182/bloodadvances.2022008258. Blood Adv. 2022. PMID: 36075016 Free PMC article.
The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study.
Alzahrani M, El-Galaly TC, Hutchings M, Hansen JW, Loft A, Johnsen HE, Iyer V, Wilson D, Sehn LH, Savage KJ, Connors JM, Gascoyne RD, Johansen P, Clasen-Linde E, Brown P, Villa D. Alzahrani M, et al. Among authors: wilson d. Ann Oncol. 2016 Jun;27(6):1095-1099. doi: 10.1093/annonc/mdw137. Epub 2016 Mar 21. Ann Oncol. 2016. PMID: 27002106 Free article.
10,637 results
You have reached the last available page of results. Please see the User Guide for more information.